Find and Pitch Jounalists, Get Your Story Covered

Tags: MDMA ecstasy PTSD therapy denver denver botanic garden

	Profile	Recent Articles on Subject
1	Kristen Monaco MedPage Today	Psych Congress Roundup: Digital Tx for MDD; Esketamine Rooms; PA Contributions - 11 days ago More ADHD Drug Production; Psilocybin vs Lexapro; Addiction a Chronic Brain Disease? - 2 months ago FDA Rejects MDMA-Assisted Therapy for PTSD - 3 months ago MDMA for PTSD Under FDA Review; GLP-1 for Opioid Cravings; ADHD an Evolutionary Aid? - 9 months ago Psychedelics for Psych Conditions Made Their Mark in 2023 - 11 months ago Another Mid-Stage Psychedelic Win; Gun Suicides Reach High; Magnetic Seizure Therapy - 12 months ago
2	Marissa Plescia MedCity News Reporter at MedCity News. reportingjournalism	What’s Next for Psychedelic Medicines? - 18 days ago
3	Oshan Jarow Vox Focus on consciousness, economics. Co-founder LE Possibility. Brooklyn, New York consciousnesseconomicspodcasting	Nitrous, one of the oldest mind-altering drugs, is back - about 2 months ago MDMA therapy didn’t get FDA approval. Now what? - 3 months ago Psychedelics are about to become a casualty of Oregon’s opioid crisis - 8 months ago Why psychedelics produce some of the most meaningful experiences in people’s lives - 12 months ago Psychedelics can have enormous benefits, but the risks shouldn’t be ignored - about 1 year ago
4	Sophie Putka MedPage Today Enterprise, investigative writer. New York, USA enterprise journalisminvestigative journalism	A Miss for Steroid-Toting Red Blood Cells in Ataxia Telangiectasia - 3 months ago
5	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	STAT+: Rick Doblin, ‘unleashed,’ blasts FDA over Lykos drug rejection and turns to global push for MDMA therapy - 3 months ago STAT+: Lykos Therapeutics cuts 75% of staff after FDA rejects MDMA-assisted therapy - 3 months ago A tough week for MDMA-assisted psychotherapy - 3 months ago STAT+: Three MDMA therapy papers retracted over data integrity concerns - 3 months ago FDA rejects MDMA as a psychedelic treatment for PTSD - 3 months ago Psychedelic investment continues to ramp up - 9 months ago
6	Emily Mullin Wired Staff writer at WIRED. Covers biotechnology. Fall 2021 fellow. Pittsburgh, Pennsylvania biotechnology	The Uncertain Path Forward for Psychedelic Medicine - 3 months ago The FDA Just Rejected a Bid for MDMA to Treat PTSD - 3 months ago The Case for MDMA’s Approval Is Riddled With Problems - 5 months ago
7	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about FDA rejecting MDMA; a nasal spray for allergic reactions, and more - 3 months ago STAT+: Pharmalittle: Lilly wins FDA approval for a weight-loss drug; AstraZeneca enters the race for an obesity pill - about 1 year ago STAT+: Pharmalittle: China arrests an Astellas exec accused of spying; weight-loss drugs are being tested in children - about 1 year ago STAT+: Pharmalittle: More than 9 in 10 pharmacy techs report drug shortages; Yale and VA strike deal over ketamine patent royalties - about 1 year ago
8	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Declines to Approve MDMA for PTSD - 3 months ago Is 2024 the Year for Psychedelic Medicine? - 8 months ago FDA Accepts New Drug Application for MDMA-Assisted Therapy for PTSD - 9 months ago
9	N. Adam Brown MD MedPage Today Healthcare Strategist/Communicator. Washington, D.C. Healthcarestrategycommunication	The Promise of 'Magic Mushrooms' for Mental Health Is Real - 4 months ago
10	Clare Watson Science Alert Science writer. Wollongong, Dharawal country sciencefreelance journalism	Common Sedative Could Break Consciousness by Tipping Your Brain Into Chaos - 4 months ago

Journalists covering ecstasy